Xiong et al. reported that Infliximab (another non-selective anti-TNF therapy) could inhibit aneurysm growth, attenuate elastic fiber disruption, and reduce macrophage infiltration in a CaCl2-induced AAA murine model (16), indicating that this strategy of TNF-antagonism may also apply to the treatment of AAA. Here, TNF is linked to triple-A syndrome.